Maharashtra’ Food and Drug Administration has ordered an FIR against eCommerce giant Snapdeal founders Kunal Bahl and other directors for allegedly selling prescription based drugs on the website. The FDA had asked the company to furnish documents pertaining to the distribution and sale
Recent Posts
- Dr. Koushik Lahiri Issues Urgent Global Clarion Call Against Steroid Dependence Crisis at 17th Pharma Leaders Summit
- Beyond Generics: Venkat Nelabhotla Unveils the ‘Develop, Own, Make’ Blueprint for India’s Global Biotech Ascension
- The Rural Health Crisis: Why Free Policies Aren’t Saving Lives in Deep India
- The Cold Card: How Bureaucratic Paperwork Turned Odisha’s Senior Healthcare Promise into a Hospital Gate Crisis
- Pharma Titans & Healthcare Visionaries Honoured — Healthcare Super Brand Awards 2026 Redefine Global Standards at Pharma Leaders Annual Awards










